CDSCO steps up scrutiny of pharma drugs containing narcotic substances

The Central Drugs Standard Control Organisation is addressing regulatory gaps related to the illegal diversion of pharmaceutical drugs. Following the National Committee for Coordination on Drug Trafficking meeting, specific targets have been assig...

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) is reviewing its regulatory framework to identify gaps and stop the illegal diversion of pharmaceutical drugs containing narcotic drugs and psychotropic substances.

The move follows the 10th apex level National Committee for Coordination on Drug Trafficking (NCORD) meeting held in June under the chairmanship of Union home minister Amit Shah, where the CDSCO was tasked with addressing regulatory gaps to control illegal diversion of drugs by March 2027.

Also Read: Drug regulator warns against prolonged use of painkillers, antibiotics


The vision document on drug control (2026-2029) sets out a coordinated framework to address the evolving drug trafficking and drug abuse in the country, with defined responsibilities, timelines, targets and monitoring mechanisms. ET has seen a copy of the document.

Under the document, the CDSCO has been assigned a key role in preventing the diversion of pharmaceutical drugs containing NDPS. One of the specific targets assigned to the drug regulator is to "address regulatory gaps to control illegal pharma diversion" by March next year.

CDSCO's action plan
CDSCO's action plan
The matter has now been placed before the drugs consultative committee (DCC), which will examine whether gaps in the existing regulatory framework or its implementation could be contributing to the diversion of pharmaceutical preparations containing NDPS. The committee will deliberate and recommend appropriate measures to strengthen the regulatory mechanism in this regard.
ADVERTISEMENT

The recommendations of DCC are expected to be considered by CDSCO for formulating an appropriate action plan. The move is part of a broader government focus on strengthening country's response to changing patterns of drug trafficking.

Also Read: Government to ease BA-BE study norms for domestic generic drug approvals, cut import licence timelines

At the NCORD meeting, Shah highlighted the increasing use of encrypted communication, darknet platforms, cryptocurrencies, synthetic drugs and drones by organised criminal networks. He emphasised that the illicit drug ecosystem had evolved into an organised, tech-enabled and transnational criminal enterprise, and that seizure-centric policing alone would not be adequate to counter the emerging threats.

Shah highlighted the incidence of drug abuse among youth and stressed the need for a tech-driven and intelligence-led strategy encompassing supply reduction, demand reduction, treatment, rehabilitation and capacity building.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Industry › Healthcare/Biotech › Pharmaceuticals › CDSCO steps up scrutiny of pharma drugs containing narcotic substances
Text Size:AAA
Success
This article has been saved

*

+